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Abstract An improved internal gelation approach is
developed to encapsulate single mammalian cells in
monodisperse alginate microbeads as small as 26 lm in
diameter and at rates of up to 1 kHz with high cell via-
bility. The cell damage resulting from contact with calcium
carbonate nanoparticles as gelation reagents is eliminated
by employing a co-flow microfluidic device, and the cell
exposure to low pH is minimized by a chemically balanced
off-chip gelation step. These modifications significantly
improve the viability of cells encapsulated in gelled algi-
nate particles. Two different mammalian cell types are
encapsulated with viability of over 84 %. The cells are
functional and continue to grow inside the microparticles.
Keywords Single cell encapsulation  Alginate 
Droplet-based microfluidics
1 Introduction
Cell encapsulation in hydrogel microbeads has promising
applications in tissue engineering, regenerative medicine,
and cell-based drug delivery (Drury and Mooney 2003;
Pierige` et al. 2008; Slaughter et al. 2009; Schmidt et al.
2008; Nicodemus and Bryant 2008; Xu et al. 2009).
Encapsulated cells can secrete therapeutic proteins in
response to an external stimulus over an extended time
period to treat various diseases including renal failure and
diabetes (Sun et al. 1996; Prakash and Chang 1996). In cell
transplantation therapy for ischemic heart diseases, direct
injection of cells results in limited cell survival, while
encapsulation in hydrogels improves cell growth and
transplantation efficiency (Chachques et al. 2007; Yu et al.
2010). Of all hydrogels, alginate is one of the most suitable
biomaterials for cell encapsulation due to its biocompati-
bility, biodegradability, similarities to the natural extra-
cellular matrix, and ease of gelation (Lee and Mooney
2012). Alginate is a naturally derived polymer, which can
physically cross-link with divalent ions to provide an ideal
three-dimensional scaffold for cells that allows bidirec-
tional diffusion of nutrients and waste products.
Alginate particles are typically produced by ejecting
drops of alginate solution into a bath of divalent ions
resulting in millimeter-sized polydisperse beads (Maguire
et al. 2006; Hoesli et al. 2011; Mazzitelli et al. 2011).
However, for use as carriers of drugs, proteins, or cells, it is
desirable to precisely control particle size and monodis-
persity. Droplet-based microfluidics offers a powerful
method to rapidly produce monodisperse alginate micro-
droplets with diameters of up to a few hundred micrometers
(Tan and Takeuchi 2007; Capretto et al. 2008; Workman
et al. 2008; Martinez et al. 2012; Teh et al. 2008; Choi et al.
2007). Smaller hydrogel particles (\50 lm in diameter) are
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preferred for cell encapsulation because the small size: (1)
enhances diffusion of oxygen and nutrients, improving cell
viability over long periods of time (Drury and Mooney
2003; Sugiura et al. 2005); (2) decreases the sample volume
and reaction times, enabling high-throughput single cell
studies (Edd et al. 2008; Guo et al. 2012); (3) reduces the
cellular reaction and the immune response to the particles
(Sakai et al. 2006) and also facilitates particle injection for
cell transplantation therapies (Yu et al. 2010); and (4)
allows the particles to be sorted through the use of standard
fluorescence-activated cell sorting (FACS) methods. How-
ever, producing small particles is challenging due to the
high fluidic resistance of the viscous polymeric solutions in
narrow microchannels increasing the inlet pressure for
injection and therefore debonding the channels. Moreover,
the in situ gelation of droplets in the microfluidic device
quickly clogs the microchannels. Several gelation strate-
gies, mainly based on an external or internal source of
divalent ions, are used to polymerize the alginate drops. In
the external gelation approach, divalent ions, generally
Ca2?, are added either by merging alginate drops to aqueous
Ca2? drops or by co-flowing alginate and calcium chloride
(CaCl2) solutions separated by a water stream through a
microfluidic device (Choi et al. 2007; Shintaku et al. 2007).
The use of aqueous drops to provide Ca2?, or the use of a
water stream to keep the alginate and CaCl2 separate until
drop formation, reduces the final concentration of alginate
and therefore limits the stiffness of the microbeads. Addi-
tionally, the rapid gelation rate of these methods produces
heterogeneous and mostly non-spherical particles (Martinez
et al. 2012; Um et al. 2008). An alternative approach,
internal gelation, allows better control over the particles’
size and homogeneity (Tan and Takeuchi 2007; Workman
et al. 2008). Tan and Takeuchi (2007) combined the internal
gelation approach with droplet-based microfluidics in
which a stream of alginate solution containing cells and
CaCO3 nanoparticles is used to form droplets, and then a
stream of acidic oil is added to release the calcium ions and
effect in situ gelation. They reported monodisperse particles
as small as 94 lm diameter with 74 % cell viability.
However, in their approach, the cell viability directly
depends on the CaCO3 concentration, making it difficult to
tune the particle stiffness by varying the CaCO3 concen-
tration. Moreover, dispersion of the cells and CaCO3
nanoparticles in the same alginate solution increases direct
mechanical contact between them, which physically dam-
ages and breaks the cells prior to drop formation.
Here, we present an improved internal gelation tech-
nique to encapsulate mammalian cells in alginate micro-
particles as small as 26 lm in diameter with high viability
independent of CaCO3 concentration. By adding the stoi-
chiometric equivalent of acetic acid with respect to the
CaCO3 concentration to the collected droplets and quickly
transferring the gelled particles to fresh cell growth med-
ium, the exposure of the encapsulated cells to low pH is
minimized. The physical damage to the cells by CaCO3
nanoparticles is also prevented by flowing the cells and the
CaCO3 nanoparticles in two separate streams of alginate
solution prior to drop formation. Protecting the cells from
chemical and mechanical harm during encapsulation
increased the cell viability to 84 % after encapsulation.
2 Results and discussion
In our initial effort to duplicate the conventional internal
gelation technique in which cells and calcium carbonate
nanoparticles are suspended in the same alginate solution,
we observed that direct mechanical contact between the
cells and particles severely damaged the cells prior to drop
formation. Cell breakage, obvious from the cell debris
trapped in the inlet filter, is shown in Fig. 1, prevented an
accurate measurement of cell viability.
To address this problem, we designed a microfluidic
device consisting of three inlets with two flow-focusing
junctions in series, as shown in Fig. 2. An aqueous alginate
solution containing the cells is introduced into the right-
most inlet, labeled inlet 3 in Fig. 2a, and another solution
containing the CaCO3 nanoparticles is injected into the
middle inlet. In the first junction, these fluids form a
coaxial stream that extends into the second junction, where
it is pinched off by oil into droplets, as shown in Fig. 2a, b.
The nanoparticle-containing solution and the cell-contain-
ing solution have equal alginate concentrations; thus,
mixing channels, which squeeze the drops and introduce
further damage to the cells, are unnecessary.
Fig. 1 Following the conventional internal gelation approach, a
solution containing alginate, cells, and CaCO3 nanoparticles was
injected into a microfluidic device. Cells were damaged by contact with
the CaCO3 nanoparticles, resulting in the cell debris trapped in filter of
the inlet channel of the microfluidic device. The scale bar is 50 lm
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To maintain the viability of the encapsulated cells, the
gelation process must be precisely controlled. Previously
reported techniques based on internal gelation utilize an
acidic oil stream to release the Ca2? ions of insoluble
CaCO3 particles and polymerize the alginate particles.
This can result in prolonged exposure of the cells to low
pH, reducing cell viability. To minimize the pH reduction
in the particles during gelation, a stoichiometric equiva-
lent of acetic acid with respect to the CaCO3 is used, off-
chip, after droplet collection. This amount is determined
by: (1) calculating the molar quantity of CaCO3 in the
collected drops based on its initial concentration in algi-
nate solution, the flow rates and the duration of drop
collection; (2) determining the stoichiometric equivalent
of acetic acid with respect to the moles of CaCO3 using
Eq. (1).
2CH3COOH þ CaCO3 ! Ca CH3COOð Þ2þ H2O
þ CO2 ð1Þ
Finally, the acetic acid dissolved in oil (0.1 % v/v) is
added to the drops causing gelation by diffusion into the
droplets. After gelation, the surfactant is dissolved and the
particles are washed three times with fresh cell growth
medium to ensure all oil, and surfactant is removed and
that optimal pH is restored. The gelation and washing steps
are performed in 1–2 min.
To verify the effectiveness of this technique, we
encapsulated antibody-secreting hybridoma cells (9E10
cell line) and mouse breast cancer cells (M6C cell line)
within alginate microparticles. In Fig. 3a, droplets con-
taining cells and CaCO3 nanoparticles are shown in oil
prior to gelation; in Fig. 3b, cell-containing microparti-
cles are shown following their gelation and transfer to
cell growth medium. To evaluate cell viability, the cells
were stained with calcein AM (live stain, green) and
ethidium homodimer (dead stain, red). A total of 84 %
of 9E10 cells and 86 % of M6C cells were viable when
assayed after the encapsulation and washing process. To
test long-term viability, M6C cells were encapsulated
into particles and incubated for 6 days, as shown in
Fig. 3c. The viability decreases to 74 % at day 2 and
increases to 84 % after 6 days due to cell division and
growth.
Notably, MC6 cells continue to grow within these par-
ticles, forming multicellular colonies after 6 days of cul-
ture (Fig. 4). This feature is potentially very useful; for
example, cancer cells might be grown into pseudo-tumors
in these particles to provide a cost-effective tool to test new
anti-cancer drugs.
Fig. 2 a Schematic representation of the drop maker device with
three inlets and two consecutive junctions. Aqueous alginate solutions
containing CaCO3 nanoparticles and cells are introduced into inlets 2
and 3, respectively, while the oil phase containing surfactant is
injected into inlet 1. In the first junction, a coaxial stream consisting
of the cell-containing inner fluid, surrounded by the nanoparticle-
containing outer fluid, is formed. The coaxial stream extends into the
second junction, where it is pinched off by the oil into droplets.
b Bright-field image of the flow-focusing junctions. Prior to droplet
formation, the cells are completely protected from direct mechanical
contact with the CaCO3 nanoparticles. The scale bar is 50 lm
Fig. 3 a Bright-field image of 35-lm alginate droplets in oil, prior to
gelation. Droplets contain cells and CaCO3 nanoparticles. b Confocal
microscopic image of the encapsulated cells inside the alginate
microparticles after gelation and transfer to cell growth medium.
Green fluorescence represents live cells stained by calcein AM.
c Percentage viability of M6C cells determined from the fraction of
live cells before and after encapsulation. The scale bars are 25 lm
(color figure online)
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3 Conclusion
We introduced an effective microfluidic-based technique to
encapsulate single cells in monodisperse alginate micro-
particles. Our method protects cells against mechanical and
chemical harm during drop formation and gelation. The
encapsulated cells have a high survival rate and are capable
of proliferation inside the particles making the present
method reliable and valuable for research applications such
as cell transplantation, tissue engineering, and high-
throughput cell analysis.
4 Materials and methods
4.1 Microfluidic device fabrication
The microfluidic device with channel dimensions of 20 lm
in width and 25 lm in height was fabricated using soft
lithography in polydimethylsiloxane (PDMS, Sylgard 184,
Dow Corning). To make the channels hydrophobic and
prevent wetting, they were coated with Aquapel (PPG
Industries, Pittsburgh, PA). Syringe pumps (Harvard
Apparatus) were used to control the flow rates.
4.2 Preparation of fluids
Sterile alginate Pronova SLG100 (Novamatrix, Norway)
was dissolved in 10 ml of cell growth medium containing
89 % v/v CO2-independent DMEM (Gibco, Grand Island,
NY), 10 % v/v FBS (Gibco), and 1 % v/v Penstrep (Gibco) to
prepare 2.5 % w/w alginate solution. Based on the desired
concentration of alginate microparticles, this solution was
further diluted with cell growth medium and OptiPrep (Axis-
shield, Norway). OptiPrep, typically used to prepare density
gradients, is included at 16 % final concentration (v/v) to
match the density of the alginate solution with that of the
cells so that cells remain suspended during particle making.
In the presented results, we have used two 1.5 % w/w
alginate solutions: one containing the cells, and the other one
with 70 mM calcium carbonate nanoparticles. We used the
same flow rate for both of the solutions resulting in droplets
of 35 mM CaCO3 and 1.5 % w/w alginate. Fluorinated
surfactant (Holtze et al. 2008) dissolved in Novec 7500
flurocarbon oil (1 % w/w) was used to stabilize droplets in oil
phase and prevent drop coalescence.
4.3 Gelation and washing process
Prior to dropmaking, an acidic oil solution was prepared by
dissolving 1 ll glacial acetic acid (Sigma, St. Louis, MO) in
1 ml oil (Novec 7500, 3M, St Paul, MN) resulting in
17.5 mM acidic oil solution. During dropmaking, droplets
were collected every 20 min. The molar amount of calcium
carbonate in the collected drops was calculated according to
the flow rate of aqueous solution, and the stoichiometric
equivalent of acetic acid dissolved in oil was added to the
collected drops to initiate gelation. Then, the particles were
gently pipetted up and down for 5 s to accelerate diffusion of
the acid throughout the CaCO3 nanoparticles, dissolving
them and releasing Ca2? ions. Next, the emulsion was cen-
trifuged at 200 rpm for 3 s, and the oil phase was removed.
Then, 1 ml of 20 % v/v of PFO (1H,1H,2H,2H-perfluoro-1-
octanol 97 %, Sigma-Aldrich, USA) in Novec 7500 oil was
added to release the surfactant from the particles. The mixture
was centrifuged at 200 rpm for 3 s, and the oil/PFO phase
was removed. The particles were then washed twice with
fresh cell growth medium (centrifuging for 30 s at 300 rpm)
to ensure that all acidic oil was removed. The particles
resuspended in fresh growth medium and transferred to a
48-well plate and incubated at 37 8C and 5 % CO2.
4.4 Viability measurement
We examined the cell viability using a Live–Dead assay
kit, calcein (Invitrogen, Carlsbad, CA, live stain, green
fluorescence) and ethidium homodimer-1 (Invitrogen, dead
stain, red fluorescence). Four microliters of ethidium and
1 ll of 50 lM calcein are added to 1 ml of cell growth
medium containing alginate particles encapsulating cells
and incubated for 30 min in room temperature in dark.
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